source
- FDA advisory panel backs Grail's Galleri multi-cancer blood test, citing benefits outweigh risksThe Food and Drug Administration’s advisory committee voted to endorse Galleri, a blood test from Grail that screens for multiple cancers, saying the benefits outweigh the risks. The panel’s vote…
- AI-driven biotech Enveda secures $311 million Series E to advance plant-derived drug candidatesEnveda Biosciences, a Colorado AI drug discovery company, announced a $311 million Series E financing round, one of the larger biotech raises this year. The firm uses artificial intelligence to sc…